Insider Buying: Diagnos Inc (CVE:ADK) Insider Buys C$17,000.00 in Stock

Diagnos Inc (CVE:ADK) insider Tristram Coffin purchased 100,000 shares of the firm’s stock in a transaction that occurred on Friday, July 24th. The shares were acquired at an average cost of C$0.17 per share, with a total value of C$17,000.00. Following the completion of the transaction, the insider now owns 2,103,934 shares in the company, valued at approximately C$357,668.78.

The firm has a 50 day moving average of C$0.16 and a 200-day moving average of C$0.20. The stock has a market capitalization of $9.82 million and a price-to-earnings ratio of -1.87. Diagnos Inc has a 52-week low of C$0.10 and a 52-week high of C$0.33. The company has a quick ratio of 3.65, a current ratio of 4.02 and a debt-to-equity ratio of 18.56.

Diagnos (CVE:ADK) last posted its earnings results on Friday, June 5th. The company reported C($0.02) earnings per share (EPS) for the quarter. The firm had revenue of C$0.08 million during the quarter.

About Diagnos

DIAGNOS Inc provides software-based interpretation services primarily in Canada, the United Arab Emirates, Saudi Arabia, Slovakia, and the United States. It offers image analysis services through Computer Assisted Retinal Analysis, a software tool that assists health specialists in the detection of diabetic retinopathy.

Further Reading: Google Finance

Receive News & Ratings for Diagnos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diagnos and related companies with MarketBeat.com's FREE daily email newsletter.